Unveiling fatty acid subtypes: immunometabolic interplay and therapeutic opportunities in gastric cancer
This developed FAM signature demonstrated potential as a biomarker for guiding treatment and predicting prognosis in GC.
Authors
- Huahuan Liu
- Ye Edward Tian (ORCID: https://orcid.org/0000-0001-7053-5447)
- Liuxing Wu
- Hong Dai (ORCID: https://orcid.org/0000-0002-3009-5536)
- Xiangnan Zhang (ORCID: https://orcid.org/0000-0002-7603-7403)
- Yanxin Yao (ORCID: https://orcid.org/0000-0002-1485-9831)
- Ben Liu (ORCID: https://orcid.org/0000-0001-8452-5397)
- Kexin Chen (ORCID: https://orcid.org/0000-0003-4248-7681)
- Xin Hu
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3389/fonc.2025.1570873
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China